Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Jordan

Showing results (301-310 of 1,873) with videos related to

Pageof 188
Sort By:
Molecular Pharmacology|September 1, 1984
Estrogen-stimulated prolactin synthesis in vitro. Classification of agonist, partial agonist, and antagonist actions based on structureV C Jordan, M E Lieberman
Current Opinion in Neurology|November 15, 2006
Disorders of speech and language: aphasia, apraxia and dysarthriaLori C Jordan, Argye E Hillis
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Presensitization: the problem and its managementStanley C Jordan, Mark D Pescovitz
European Journal of Cancer & Clinical Oncology|December 1, 1987
Adaptation of estrogen-dependent MCF-7 cells to low estrogen (phenol red-free) cultureW V Welshons, V C Jordan
Biophysical Journal|June 11, 2004
Ionic permeation free energy in gramicidin: a semimicroscopic perspectiveVladimir L Dorman, Peter C Jordan
Journal of Learning Disabilities|October 22, 2004
Mathematical thinking in second-grade children with different forms of LDN C Jordan, L B Hanich
Receptor|January 1, 1990
The biological significance of the interaction of estrogen agonists and antagonists with the estrogen receptorC S Murphy, V C Jordan
The Journal of Antibiotics|September 1, 1972
Laboratory production and 14 C-labelling of viomycinA H Tam, D C Jordan
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Selective oestrogen receptor modulation: molecular pharmacology for the millenniumA S Levenson, V C Jordan
Hematology/Oncology Clinics of North America|June 11, 1999
Hormonal therapy for breast cancer. An updateW J Gradishar, V C Jordan
Pageof 188

Showing results (301-310 of 1,873) with videos related to

Sort By:
Pageof 188
Molecular Pharmacology|September 1, 1984
Estrogen-stimulated prolactin synthesis in vitro. Classification of agonist, partial agonist, and antagonist actions based on structureV C Jordan, M E Lieberman
Current Opinion in Neurology|November 15, 2006
Disorders of speech and language: aphasia, apraxia and dysarthriaLori C Jordan, Argye E Hillis
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Presensitization: the problem and its managementStanley C Jordan, Mark D Pescovitz
European Journal of Cancer & Clinical Oncology|December 1, 1987
Adaptation of estrogen-dependent MCF-7 cells to low estrogen (phenol red-free) cultureW V Welshons, V C Jordan
Biophysical Journal|June 11, 2004
Ionic permeation free energy in gramicidin: a semimicroscopic perspectiveVladimir L Dorman, Peter C Jordan
Journal of Learning Disabilities|October 22, 2004
Mathematical thinking in second-grade children with different forms of LDN C Jordan, L B Hanich
Receptor|January 1, 1990
The biological significance of the interaction of estrogen agonists and antagonists with the estrogen receptorC S Murphy, V C Jordan
The Journal of Antibiotics|September 1, 1972
Laboratory production and 14 C-labelling of viomycinA H Tam, D C Jordan
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Selective oestrogen receptor modulation: molecular pharmacology for the millenniumA S Levenson, V C Jordan
Hematology/Oncology Clinics of North America|June 11, 1999
Hormonal therapy for breast cancer. An updateW J Gradishar, V C Jordan
Pageof 188